Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study

January 2007
BMC Public Health;2007, Vol. 7 Issue 1, p291
Academic Journal
No abstract available.


Related Articles

  • Treatment outcome of extra-pulmonary tuberculosis in Finland: a cohort study. Vasankari, Tuula; Holmström, Pekka; Ollgren, Jukka; Liippo, Kari; Ruutu, Petri // BMC Public Health;2010, Vol. 10 Issue 1, p399 

    Background: We investigated the treatments given, the outcome and the patient- and treatment-system dependent factors affecting treatment outcome in a national two-year cohort of culture-verified extra-pulmonary tuberculosis cases in Finland. Methods: Medical records of all cases in 1995 -1996...

  • Predictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005-2012. Hongjo Choi; Myungsun Lee; Chen, Ray Y.; Youngran Kim; Soyoung Yoon; Joon Sung Joh; Seung Kyu Park; Dodd, Lori E.; Jongseok Lee; Taeksun Song; Ying Cai; Goldfeder, Lisa C.; Via, Laura E.; Carroll, Matthew W.; Barry 3rd, Clifton E.; Sang-Nae Cho // BMC Infectious Diseases;2014, Vol. 14 Issue 1, p360 

    Background: Tuberculosis remains an important health concern in many countries. The aim of this study was to identify predictors of unfavorable outcomes at the end of treatment (EOT) and at the end of study (EOS; 40 months after EOT) in South Korea. Methods: New or previously treated...

  • Anti-tuberculosis drugs related hepatotoxicity; incidence, risk factors, pattern of changes in liver enzymes and outcome. Khalili, H.; Dashti-Khavidaki, S.; Rasoolinejad, M.; Rezaie, L.; Etminani, M. // DARU;Summer2009, Vol. 17 Issue 3, p163 

    Background and the purpose of the study: Tuberculosis is a curable disease if diagnosed and treated properly with anti-tuberculosis drugs. These drugs can cause severe adverse reactions including hepatotoxicity. The goal of this study was to evaluate the rate and the time of incidence, pattern...

  • Treatment outcomes among pulmonary tuberculosis patients at treatment centers in Ibadan, Nigeria. Fatiregun, Akinola A.; Ojo, Abimbola S.; Bamgboye, Afolabi E. // Annals of African Medicine;2009, Vol. 8 Issue 2, p100 

    Objective: To assess treatment outcomes and determinants of outcome among tuberculosis patients. Design: A longitudinal study design involving a cohort of sputum smear-positive pulmonary tuberculosis patients at initiation of therapy, who were followed up to the end of treatment at eighth month....

  • Tobacco smoking and tuberculosis treatment outcomes: a prospective cohort study in Georgia. Gegia, Medea; Magee, Matthew J.; Kempker, Russell R.; Kalandadze, Iagor; Chakhaia, Tsira; Golub, Jonathan E.; Blumberg, Henry M. // Bulletin of the World Health Organization;Jun2015, Vol. 93 Issue 6, p390 

    Objective To assess the effect of tobacco smoking on the outcome of tuberculosis treatment in Tbilisi, Georgia. Methods We conducted a prospective cohort study of adults with laboratory-confirmed tuberculosis from May 2011 to November 2013. History of tobacco smoking was collected using a...

  • Monitoring tuberculosis treatment outcome: analysis of national surveillance data from a clinical perspective.  // Thorax;May2008, Vol. 63 Issue 5, p440 

    Background: In 1998, the World Health Organization (WHO) and the International Union Against Tuberculosis and Lung Disease (IUATLD) published recommendations standardising the evaluation of tuberculosis treatment outcome in Europe. These guidelines fail to account for clinically appropriate...

  • Impact of the Patient-Provider Relationship on the Survival of Foreign Born Outpatients with Tuberculosis. Gardam, Michael; Verma, Geetika; Campbell, Ann; Wang, Jun; Khan, Kamran // Journal of Immigrant & Minority Health;Dec2009, Vol. 11 Issue 6, p437 

    Background Managing tuberculosis in foreign born patients entails a complex interaction between patient and provider. Methods Using a retrospective cohort study and survival analysis, this study evaluates the impact of patient and provider factors on the survival of foreign born outpatients with...

  • Adherence to isoniazid preventive therapy in Indonesian children: A quantitative and qualitative investigation.  // BMC Research Notes;2012, Vol. 5 Issue 1, p7 

    The article offers information on a study conducted by the authors related to isoniazid preventive therapy (IPT) in treatment of tuberculosis (TB) in Indonesian children. 260 children for the main cohort 150 aged below 5 and active TB was excluded in 82 children, who became part of the...

  • Preventive Therapy for Child Contacts of Multidrug-Resistant Tuberculosis: A Prospective Cohort Study. Seddon, James A.; Hesseling, Anneke C.; Finlayson, Heather; Fielding, Katherine; Cox, Helen; Hughes, Jennifer; Godfrey-Faussett, Peter; Schaaf, H. Simon // Clinical Infectious Diseases;Dec2013, Vol. 57 Issue 12, p1676 

    A 3-drug preventive regimen for the treatment of children exposed to multidrug-resistant tuberculosis was well tolerated with limited toxicity. Few children developed tuberculosis or died. This regimen should be seen as a safe and effective option.Background. Evidence is limited to guide the...

  • Efficacy of Treatment for Latent Tuberculosis in Patients Undergoing Treatment with a Tumor Necrosis Factor Antagonist. Jungsil Lee; Eunyoung Kim; Eun Jin Jang; Chang-Hoon Lee; Eun Young Lee; Jong Pil Im; Sung Koo Han; Jae-Joon Yim; Lee, Jungsil; Kim, Eunyoung; Jang, Eun Jin; Lee, Chang-Hoon; Lee, Eun Young; Im, Jong Pil; Han, Sung Koo; Yim, Jae-Joon // Annals of the American Thoracic Society;May2017, Vol. 14 Issue 5, p690 

    Rationale: Current guidelines recommend that all patients undergoing treatment with a tumor necrosis factor-α antagonist should receive screening for latent tuberculosis and appropriate treatment before initiating the inhibitor. However, no well-designed study has shown the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics